JAN 21, 2016 07:00 AM PST

Ultrasounds Improve Diagnosis for Ovarian Cancer

WRITTEN BY: Xuan Pham
New model predicts ovarian cancer risk with 98% accuracy

Ovarian cancers have one of the highest mortality rates, ranking fifth in cancer deaths among women. Early detection is key for survival; however, pre-operative diagnostic tests be inconclusive, especially for difficult-to-screen masses. Researchers now say a new adaptation on the existing “simple rules” can calculate risk for ovarian cancer with an astounding 98% accuracy.
 
The American Cancer Society estimated over 21,000 women in the US received a new diagnosis of ovarian cancer in 2015. Of these newly diagnosed women, about two thirds will succumb to the disease. Early and correct diagnoses of ovarian cancer have measureable improvements for patient survivals.
 
Ultrasound of ovarian cancer
To predict whether a mass is benign or malignant, clinicians have been applying a set of Simple Rules outlined by the International Ovarian Tumor Analysis (IOTA). These rules discriminate 10 unique features observed from ultrasounds, such as growth size and edge details of the mass. From this checklist of sorts, clinicians classify the uterine mass and decide whether or not to operate. While easy to use, the rules did have limitations.
 
"The Simple Rules are intuitively attractive because of their ease of use, however, when used as originally suggested, they allow only a categorization of tumors into three groups: benign, malignant, or inconclusive," explained Dr. Timmerman, IOTA group leader, Department of Obstetrics and Gynecology, University Hospitals Leuven, Belgium.
 
To overcome this limitation, the researchers set out to adapt the Simple Rules so that it can actually calculate the relative risk of a suspected mass being cancerous in a particular patient. They also wanted to reduce the number of “inconclusive” diagnoses given to patients using the original method.
 
In a landmark study, the researchers collected tumor data from nearly 5,000 women from 22 health centers in 10 countries spanning the course of 13 years (1999-2002). The researchers then created a mathematical algorithm that weighed each of the features in the Simple Rules based on its likelihood of being benign or malignant.
 
When the algorithm was applied ultrasounds of patient tumor masses, it produced 98% accuracy in predicting ovarian cancer risk. The malignancy rate was 34% overall, with 42 years being the median age of patients with benign tumors, and 57 years being the median age of patients with malignant tumors.
 
"A simple classification based on these risk estimates may form the basis of a clinical management approach. This will hopefully facilitate choosing optimal treatment for all patients presenting with adnexal masses."
 
In an editorial review of the study, Dr. Beryl Benacerraf, President of the American Institute of Ultrasound in Medicine (AIUM) and Clinical Professor of Radiology and OB GYN at Brigham and Women's Hospital, commented on the innovative simplicity of this new diagnostic method.
 
"The investigators have finally been able to level and elevate the playing field so that everybody can practice with expert results in this regard," Benacerraf said. "Not only have the five simple rules demonstrated that you don't have to be an expert to evaluate ovarian masses accurately, but that one can do so simply, reproducibly and reliably."
 
Additional source: Science Daily
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 29, 2018
Genetics & Genomics
APR 29, 2018
CRISPR Can Now Edit Genes Outside of the Cell
The CRISPR/Cas9 gene-editing tool was made from an immune defense system used by bacteria. Scientists have found it has many applications....
JUN 07, 2018
Clinical & Molecular DX
JUN 07, 2018
Digital Screening Vital for Detecting Breast Cancer
A combination of two digital techniques could be the best way to diagnose breast cancer. In a new study, scientists show how combining a technique called t...
JUN 21, 2018
Clinical & Molecular DX
JUN 21, 2018
Unique Gene Signature in the Blood Indicates TB Diagnosis
A unique series of genes could tell doctors that a person will develop a tuberculosis (TB) infection months before symptoms are visible. From The Francis C...
AUG 16, 2018
Clinical & Molecular DX
AUG 16, 2018
Bubbles and a blood test could detect brain tumors
Researchers have developed a proof-of-concept technique that allows them to detect brain tumor biomarkers with a simple blood test, rather than a complicat...
SEP 21, 2018
Clinical & Molecular DX
SEP 21, 2018
We will teach you to be a doctor, said us to the machine.
Clinical diagnosis are now possible in the hands of computers through machine learning. Whence, the reports of successful trials for the diagnostics....
NOV 07, 2018
Immunology
NOV 07, 2018
Inflammation Can Steal Your Sleep
A link between inflammation and the circadian rhythm has been determined in mouse models. High-fat-diets may be the cause....
Loading Comments...